US 8093236
Weekly administration of dipeptidyl peptidase inhibitors
granted A61KA61K31/513A61P
Quick answer
US patent 8093236 (Weekly administration of dipeptidyl peptidase inhibitors) held by Takeda Pharmaceutical Company Limited expires Mon Jan 05 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Takeda Pharmaceutical Company Limited
- Grant date
- Tue Jan 10 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 05 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 12
- CPC classes
- A61K, A61K31/513, A61P, A61P1/00, A61P3/04